Universe Pharmaceuticals Inc (UPC)
2.39
+0.07
(+3.13%)
USD |
NASDAQ |
May 01, 16:00
2.39
0.00 (0.00%)
After-Hours: 20:00
Universe Pharmaceuticals Shareholders Equity (Quarterly): 39.53M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 39.53M |
| March 31, 2023 | 47.13M |
| March 31, 2023 | 47.13M |
| September 30, 2022 | 46.44M |
| March 31, 2022 | 61.16M |
| March 31, 2022 | 61.16M |
| September 30, 2021 | 58.93M |
| Date | Value |
|---|---|
| March 31, 2021 | 50.69M |
| March 31, 2021 | 50.69M |
| September 30, 2020 | 20.80M |
| March 31, 2020 | 17.48M |
| March 31, 2020 | 17.48M |
| September 30, 2019 | 12.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
12.38M
Minimum
Sep 2019
61.16M
Maximum
Mar 2022
40.85M
Average
47.13M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Akso Health Group | 5.223M |
| Sinovac Biotech Ltd | 8.665B |
| CASI Pharmaceuticals Inc | 24.16M |
| Zai Lab Ltd | 796.12M |
| I-MAB | 337.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.29M |
| Total Liabilities (Quarterly) | 13.75M |
| Debt to Equity Ratio | 0.1387 |
| Current Ratio | 2.676 |
| Net Debt Paydown Yield | -10.32% |